PROMIS NEUROSCIENCES INC. Number of Reportable Segments
PROMIS NEUROSCIENCES INC. (PMN) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-13
- PROMIS NEUROSCIENCES INC. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- PROMIS NEUROSCIENCES INC. number of reportable segments for fiscal 2024 was 1.00 segment.
segment
| Period end | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-25 | ||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-13 | ||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-31 |
item
| Period end | Number of Reportable Segments 3 month |
|---|---|
| 2026-03-31 | 1.00 item 10-Q · filed 2026-05-12 |
| 2025-03-31 | 1.00 item 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |